Novartis to build $23B radioligand therapy site / Beckers

Ella Jeffries / beckershospitalreview - Novartis will construct a 46,000-square-foot radioligand therapy manufacturing site in Denton, Texas, as part of its $23 billion U.S. investment. The facility will be Novartis’ fifth radioligand therapy site in the U.S. and its first in Texas, according t…

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology #healthcarefinance

Saturday, February 28, 2026, 12:23 am / permalink 19926 / 3 stories in 16 days

Patient dies in MacroGenics' cancer study, FDA puts trial on hold / Endpoints

Max Gelman / endpoints - The FDA has placed a partial clinical hold on MacroGenics’ Phase 2 study in gynecologic cancers after one patient died and three others experienced life-threatening side effects, the company disclosed Tuesday. The patient who died ...

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda #oncology

Saturday, February 28, 2026, 12:23 am / permalink 19925 / 3 stories in 16 days

Cancer blood test fails to catch disease earlier in major study / Medical Express

medicalxpress - A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it.

#healthcare #publichealth #governmentpolicy #biotech #medicaldevices #oncology

Thursday, February 26, 2026, 7:24 pm / permalink 19851 / 7 stories in 18 days

More Research, Less Cancer: £250m raised to transform the future of cancer research / Cancer Research UK

Charlotte Mathé / cancerresearchuk - We’ve reached an incredible moment - £250m raised for our More Research, Less Cancer campaign. This milestone brings us more than halfway to our £400m goal and accelerates our mission to prevent, detect and treat cancer earlier and more effectively. The p…

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #oncology

Tuesday, February 24, 2026, 1:24 pm / permalink 19675 / 53 stories in 20 days

Gilead to acquire cell therapy manufacturer for $7.8B / Beckers

Paige Twenter / beckershospitalreview - In a deal worth $7.8 billion, Gilead Sciences has entered a definitive agreement to acquire Arcellx, a biotech company developing a cell therapy for multiple myeloma. Gilead announced the acquisition agreement a few months after Arcellx published positive…

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #fda #oncology

Monday, February 23, 2026, 4:23 pm / permalink 19605 / 7 stories in 21 days

Perioperative Enfortumab Vedotin Plus Pembrolizumab Improves EFS, OS and pCR in Patients with MIBC Who Are Ineligible for Cisplatin / ESMO

esmo - Findings from the KEYNOTE-905/EV-303 study

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology

Monday, February 23, 2026, 2:22 am / permalink 19558 / 15 stories in 21 days

Data and Decisions in Advanced NSCLC at the 2026 TTLC Symposia – IASLC / OncoDaily

oncodaily - International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn: “2026 TTLC Symposia Event Data and Decisions in Advanced NSCLC The treatment landscape for advanced NSCLC is evolving […]

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology

Monday, February 23, 2026, 2:22 am / permalink 19557 / 23 stories in 21 days

Mysterious Virus Hiding Inside Common Gut Bacterium Linked to Colorectal Cancer / Discover

discovermagazine - A previously unknown virus may be the key to assessing the risk of colorectal cancer and improving diagnosis.

#healthcare #publichealth #biotech #oncology

Saturday, February 21, 2026, 12:23 am / permalink 19502 / 13 stories in 23 days

Grail’s Galleri Blood Test Falls Short in Large Cancer-Screening Study, Shares Sink 50% / MedCity

Frank Vinluan / medcitynews - Despite missing statistical significance, Grail said the observation of trending improvement suggests potential for better results with more time, so the company is extending follow up by up to a year. More detailed trial results will be submitted for pre…

#healthcare #publichealth #biotech #medicaldevices #oncology

Saturday, February 21, 2026, 12:23 am / permalink 19500 / 9 stories in 23 days

Your Cat May Share the Same Cancer Genes as You, and Offer Clues for Treatment / Discover

discovermagazine - Learn how cats and humans can share key cancer mutations — and why those similarities could guide future treatment research.

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #oncology

Thursday, February 19, 2026, 9:23 pm / permalink 19449 / 3 stories in 24 days

New FDA-Approved Device Uses Electric Fields to Treat Pancreatic Cancer / Discover

discovermagazine - Learn more about the newly approved wearable treatment that disrupts pancreatic cancer tumor growth while letting patients continue daily life at home.

#healthcare #publichealth #biotech #fda #digitalhealth #medicaldevices #oncology #pancreaticcancer

Saturday, February 14, 2026, 10:21 am / permalink 19187 / 12 stories in 4 wks